Cargando…
Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
Endoscopy is an important tool in screening and monitoring inflammatory bowel disease (IBD); however, it is invasive, costly, and associated with risks to the patients. Recently, circulating microRNAs (miRNAs) have emerged as promising noninvasive biomarkers. We proposed that the expression of serum...
Autores principales: | Wang, Huiling, Zhang, Shenghong, Yu, Qiao, Yang, Guang, Guo, Jing, Li, Manying, Zeng, Zhirong, He, Yao, Chen, Baili, Chen, Minhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748929/ https://www.ncbi.nlm.nih.gov/pubmed/26844512 http://dx.doi.org/10.1097/MD.0000000000002703 |
Ejemplares similares
-
Circulating microRNAs as candidate biomarkers for the ovarian response during in vitro fertilization
por: Zhao, Hongjuan, et al.
Publicado: (2021) -
Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3
por: Li, Manying, et al.
Publicado: (2017) -
Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease
por: Wang, Huiling, et al.
Publicado: (2016) -
Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020) -
Small RNA sequencing of exosomal microRNAs reveals differential expression of microRNAs in preeclampsia
por: Ning, Hui, et al.
Publicado: (2023)